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December 2018 Newsletter  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CCTS SPARK PROGRAM: Rolling application deadline.  This program’s priorities are to support studies 
that impact clinical care and research methodologies, support students/trainees, and provide access to 
funds to generate pilot and preliminary data for external grant submissions.  For more information, click 
on this link: https://www.umassmed.edu/ccts/funding/spark-program/ 
 
 
CCTS SMALL CONFERENCE GRANTS: Rolling application deadline.  This funding facilitates the 
development of faculty-to-faculty networks within the University system.  Click on this link for more 
information: https://umassmed.edu/ccts/funding/small-conference-grants/ 
 
 
DAMON RUNYON CANCER RESEARCH FOUNDATION: Clinical Investigator Award: The Damon 
Runyon Cancer Research Foundation seeks to increase the number of young physicians entering clinical 
cancer research each year with a focus on disease-oriented research characterized by exceptional 
innovation and creativity.  The foundation provides over $600k of financial support over three years and 
also allots $100k toward the retirement of medical school debt owed by the award recipient.   
 
UMass Medical School has been invited to submit FIVE applications. UMMS internal applications are 
due by December 21, 2018.  Please submit the following information through the Limited Submission 
Application portal on the Office of Research website: (1) brief summary of candidate’s research plans 
(one page); (2) curriculum vitae; and (3) letter of support from Department Chair/Division Chief.   
 
Final Application deadline is February 1, 2019 by 4:00pm EST. 
Click here for more detailed information. 
~ CCTS SPARK Program (Small Pilot and Research Knowledge) 
~ CCTS Small Conference Grants 
~ NEW: Damon Runyon Cancer Research Foundation Award 
~ DRIVe’s EZ-BAA 
~ NEW: Growing Gene and Cell Therapy RFA Winter 2019 
~ MCCISS K12 Support and Training 
~ NEW: Mentored Career Development (KL2) Award RFA 
~ NEW: Multiple Sclerosis Research Grants 
~ NCATS Funding 
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DRIVe’s EZ-BAA APPLICATION PROCESS:  Is now open for business!  Calling all medical product 
developers, research teams, and companies! Those offering disruptive innovative approaches that will 
transform health security threats are now invited to submit abstracts using DRIVe’s simplified EZ-BAA 
process.  Applications must offer transformative innovation, products, and technologies to protect 
Americans from health security threats.  
 
In-scope priority areas include: 
• Products and solutions to reduce illness and death from sepsis as part of DRIVe’s Solving Sepsis Initiative;  
• Technologies and processes to identify infections and exposures to biological and other health threats, as outlined in the Early 
Notification to Act, Control, and Treat (ENACT) initiative; and 
• Tools and techniques to mitigate the damages and loss of life associated with catastrophic events 
 
Download the DRIVe EZ-BAA abstract submission application, click here. 
To learn more about the DRIVe EZ-BAA, click here. 
 
 
GROWING GENE AND CELL THERAPY (GGACT) RFA WINTER: The GGACT cooperative, a collaboration 
between Boston Children’s Hospital, Cincinnati Children’s Hospital Medical Center, and the University of 
California Los Angeles, was established to support investigators in rapidly translating complex gene and 
cell therapies to early phase, investigator-initiated clinical trials by providing expertise in protocol 
development and implementation, trial and data management, and regulatory affairs, as well as utilizing 
established infrastructure for preclinical models of disease and testing, process development, and GMP 
vector production and cellular manufacturing.  More information on GGACT can be found at 
www.GGACT.org.  
 
Eligible applicants must be faculty at a CTSA institution that has an established pediatric stem cell 
transplant program.  For more information, contact Maria Suarez (maria.suarez@childrens.harvard.edu).  
Letters of Intent must be submitted no later than January 7 2019.  Invited full applications will be due by 
March 22, 2019. 
 
 
MCCISS K12 TRAINING GRANTS: The Massachusetts Consortium for Cardiopulmonary Implementation 
Science Scholars (MCCISS) announces K12 training grants for 2019. MCCISS is an institutional K12 
training grant program funded by NIH to UMass Medical School, VA CHOIR and Baystate–UMMS. The goal 
is to support junior investigators who are interested in becoming independent scientists in 
cardiopulmonary disease implementation science.  Implementation science, an emerging discipline in the 
health sciences, studies the best ways to incorporate evidence-based practice into routine clinical and 
public health practice.  Scholars pursue implementation research in prevention, management and/or 
treatment of heart, lung, blood and sleep diseases, such as coronary heart disease, chronic obstructive 
pulmonary disease, venous thromboembolism, and sleep apnea.   
 
MCCISS Important Dates:  
12.10.2018 Letters of Intent due 
02.25.2019 Full Applications due 
04.01.2019 Scholar Selection 
09.01.2019 Scholar Appointments 
 
For more information or to receive an electronic copy of the Request for Applications, 
please visit www.umassmed.edu/mcciss/ 
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The Massachusetts Consortium for Cardiopulmonary Implementation Science Scholars is supported by the National Heart, Lung, And Blood 
Institute of the National Institutes of Health under Award Number K12HL138049. 
 
 
MENTORED CAREER DEVELOPMENT (KL2) AWARD REQUEST FOR APPLICATIONS: BACKGROUND 
A major goal of the University of Massachusetts Center for Clinical and Translational Science 
(UMCCTS) is to develop and support the next generation of leaders in clinical and translational 
research. Success in today’s complex and competitive environment requires training that is truly 
transdisciplinary in nature, encompassing the full spectrum of translational research from discovery 
through pre-clinical development and first-in-human studies to implementation science with 
additional continuous feedback to basic science research.  The KL2 Training Program will combine 
coursework, seminars, and mentored research.  
 
APPLICATION: Letter of Intent due by 02.15.2019 5:00pm EST.  Must be submitted in single .DOC or 
.PDF format with supporting documentation.  Email to CCTS@umassmed.edu 
 
Interested applicants can attend an informational meeting on: 01.16.2019 from 12-1pm, Med School 
Building S3-825 (Vascular Surgery Conference Room). This meeting will clarify expectations for the 
program and answer questions. 
 
KL2 PROGRAM / PROPOSAL Questions GRANT PREPARATION / SUBMISSION Questions 
Contact: KL2 Program Leaders 
  Dr. John Keaney (john.keaney@umassmed.edu) 
  Dr. Jeroan Allison (jeroan.allison@umassmed.edu) 
  Dr. Milagros C. Rosal (milagros.rosal@umassmed.edu) 
  Dr. Javier Irazoqui (Javier.irazoqui@umassmed.edu) 
 
Contact:  
  Dr. Nathaniel Hafer (nathaniel.hafer@umassmed.edu) 
 
 
For full information, visit: http://www.umassmed.edu/ccts/education/KL2-training-program/ 
 
 
MULTIPLE SCLEROSIS RESEARCH GRANTS: The National Multiple Sclerosis Society is seeking 
proposals for innovative research with relevance to its research funding priorities.   
 
~ Pilot research grants pre-application deadline is January 7, 2019; full application deadline is January 
9, 2019 by 5:00pm EST. 
~ Research grants pre-application deadline is February 6, 2019; full application deadline is February 
13, 2019 at 5:00pm EST.   
 
For more information on research grants, click here; 
for more information on pilot research grants, click here. 
 
 
NCATS FUNDING: NCATS has announced funding opportunities to use partially developed therapeutic 
candidates to identify new treatments for a broad range of diseases. For full details, click on this link: 
https://ncats.nih.gov/news/releases/2018/ntu-foa-2018 
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~ K CLUB 
~ PiPSS (Projects in Process Seminar Series) 
 
 
K CLUB: Meets every 1st and 3rd Wednesday from 4:00pm to 5:00pm in S2-160 to provide information 
and feedback on Research Career Award applications (NIH K Awards, VA Research Career Awards, CTSA 
K grants, etc). Participants receive feedback on their biosketch, training plans, research plan, specific 
aims, and a wealth of other information.   
 
For more information, visit: https://www.umassmed.edu/ccts/education/k-club 
 
 
PiPSS: The Projects in Process Seminar Series (PiPSS) is designed to give CCTS trainees and junior faculty 
an opportunity to present their work in a structured format and in a forum of peers and faculty, with the 
goal of ensuring continuous, professional feedback and cross-fertilization that is required for excellence 
in research.  Sessions are held monthly on the 1st and 3rd Thursdays of each month – October 18, 
2018 through May 2, 2019 beginning at 3:30pm in ASC8.2072 (Albert Sherman Building). 
 
The December 6th speakers will be: 
 
→ Zachary Milstone, MD/PhD “Epigenetic Regulation of Energy Production During Cardiac 
Development” 
 
→ Eric Schmidt, MD/PhD “Investigation of a Misfolded, Destabilized Profilin-1 Species as a Toxic 
Molecule in ALS Pathogenesis” 
 
→ Apurv Soni, MD/PhD “Predictive Algorithm to Identify Infants At-Risk for Child Undernutrition in 
India” 
 
The December 20th speakers will be: 
 
→ Peter Cruz-Gordillo, MD/PhD “Adaptive Resistance: Towards Understanding Drug-Induced 
Cellular Plasticity in TNBC” 
 
→ Kristin Murphy, CRISP “Facilitating Social Emotional Learning in Young Children with Dialogic 
Reading and Mixed Reality Simulations” 
 
→ Stephanie Carreiro, K/Millennium “Wearable Sensors to Evaluate the Evolution of Opioid 
Tolerance and Dependance” 
 
→ Meera Sreedhara “Assessing the Quality of Healthy Eating and Physical Activity Policy Strategies in 
Community Health Improvement Plans” 
 
The January 3rd speakers will be: 
 
→ Tyler Frantz, MD/PhD “Control of Pigmentation Regeneration in Danio Rerio” 
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→ Alec Gramann, MD/PhD “BMP Signaling in Melanocyte Development and Melanoma” 
 
→ Annie Hien, MD/PhD “Global Profiling of Translation by FXRP-Associated Ribosomes” 
 
→ Michael Kiritsy, MD/PhD “Dissecting Host Innate Immunity in Tuberculosis Using Engineered and 
Natural Genetic Variation” 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MOLECULAR MEDICINE SPECIAL SEMINAR: Joan J. Guinovart, PhD, Professor, University of Barcelona, 
will present a special seminar: “Lafora Disease: A Window Into Brain Glycogen Metabolism” Friday, 
December 7, 2018 at Noon, Biotech Two, 2nd Floor Conference Room.  For more information, contact 
Host Michael P. Czech 508.856.2255. 
 
 
MOLECULAR MEDICINE SPECIAL SEMINAR: Martin Myers Jr., MD/PhD, Professor, University of 
Michigan, will present a special seminar: “Role for the Brain in the Control of Body Weight and Metabolism” 
Wednesday, December 12, 2018 at Noon, Biotech Two, 3rd Floor Seminar Room.  For more information, 
contact Host Michael P. Czech 508.856.2255. 
 
 
THE OPIOID CRISIS AND THE FUTURE OF ADDICTION AND PAIN THERAPEUTICS: OPPORTUNITIES, 
TOOLS AND TECHNOLOGIES: February 7-8, 2019, Kirschstein Auditorium, Natcher Conference Center, 
NIH Campus, Bethesda MD. Speakers include Nora Volkow, George Koob, Frances Collins, Eric Nestler, 
Paul Kenny, Garret Stuber, Michael Bruchas, Clifford Woolf, Brigette Kieffer, Peter Kalivas, Ron Dror.   
 
For more information or to register by Friday, January 11, 2019, click here. 
 
~ NEW: 12.07.2018 Molecular Medicine Special Seminar: 
Joan J. Guinovart, PhD “Lafora Disease: A Window into 
Brain Glycogen Metabolism” 
~ NEW: 12.12.2018 Molecular Medicine Special Seminar: 
Martin Myers Jr., MD/PHD “Role for the Brain in the 
Control of Body Weight and Metabolism” 
~ NEW: 02.07-08.2019 The Opioid Crisis and the Future of 
Addiction and Pain Therapeutics: Opportunities, Tools 
and Technologies 
~ 8th Annual UMCCTS Community Engagement and 
Research Symposium 
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8th ANNUAL UMCCTS COMMUNITY ENGAGEMENT AND RESEARCH SYMPOSIUM: Friday, March 22, 
2019 (8:15am-1:30pm), UMass Medical School, Worcester MA.  The goals of the UMCCTS Community 
Engagement and Research Symposium is to build our shared capacity to address health issues in 
communities throughout the Commonwealth by helping attendees: (1) network; (2) learn more about 
each other’s work/interests; and (3) make connections and plan for future collaborative work.   
 
Keynote: 
Mona N. Fouad, MD, MPH, Senior Associate Dean, Diversity and Inclusion 
University of Alabama at Birmingham. 
 
Proposal Status Notifications will be emailed on December 7, 2018 
 
Registration opens on January 7, 2019. 
 
 
Questions?  Email communityengagement@umassmed.edu. 
For more information, visit www.umassmed.edu/ccts/community 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
➢ CTSA Regulatory Expertise 
➢ Diamond Portal Allows CTSA Members to Access 
➢ Share Training/Assessment Materials 
➢ HRPP QA/QI 
➢ National Center for Data to Health (CD2H) 
➢ Recruitment and Retention Toolkit 
➢ UMCCTS Intake Portal 
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CTSA Regulatory Expertise: Three North Carolina Clinical and Translational Science Awards (CTSA) 
Program hubs have collaborated to create a platform for sharing regulatory expertise and best practices. 
The Regulatory Guidance for Academic Research of Drugs and Devices (ReGARDD) Program provides 
researchers with regulatory guidance, education, and consultative support, to ultimately help them move 
promising products and novel discoveries to clinical trials. 
  
ReGARDD, which is coordinated by Duke University, the Wake Forest School of Medicine, and the 
University of North Carolina at Chapel Hill hubs with partner RTI International, officially launched in 
2015 and has been developing since. The program builds upon the existing services and knowledge of the 
North Carolina CTSA Program Regulatory Groups and the Research Triangle Park (RTP). 
 
Read the full story here.  Visit the ReGARDD website here. 
 
 
DIAMOND PORTAL: To address the need for consistent training assessment and measures of 
competency, the Michigan Institute for Clinical & Health Research (MICHR) has collaborated with the 
Ohio State University, Rochester University, and Tufts University to launch the DIAMOND Portal. It is a 
pioneering digital collection that serves as a sustainable, federated database for members of clinical and 
translational research study teams to share and access training and assessment resources. For more 
information, visit https://www.michr.umich.edu/news/2018/10/15/new-diamond-portal-allows-ctsa-
members-to-access-share-training-and-assessment-materials 
 
 
HRPP QA/QI: The Human Research Protection Program (HRPP) Quality Assurance/Quality 
Improvement (QA/QI) Program is a component of the UMass Center for Clinical and Translational 
Science. The program is independent of the IRB and helps study teams and investigators by conducting 
routine post-approval monitoring of on-going research to evaluate adherence with institutional 
requirements and federal regulations. If there are review findings, the QA/QI manager shares those 
findings with investigators and study teams, and provides direct education on the findings, including how 
to avoid making similar errors in the future. In order to support improvement at an institutional level, the 
QA/QI manager shares aggregated data from reviews with the HRPP leadership and the Research 
Community to identify trends and target areas for education. The program also makes self-evaluation 
tools available to investigators and study teams seeking to perform their own assessments.  To learn 
more about HRPP QA/QI HRP-142, visit: https://www.umassmed.edu/globalassets/ccts/ccts-
media/irb/updated-sops-2015/hrp-142-hrpp-qa-qi-program-final.pdf. 
 
 
NATIONAL CENTER FOR DATA TO HEALTH (CD2H): The goal of CD2H is to make data more 
meaningful, open and accessible. The CD2H supports a vibrant and evolving collaborative informative 
ecosystem for the CTSA program and beyond. The CD2H harnesses and expands an ecosystem for 
translational scientists to discover and share their software, data and other research resources within the 
CTSA program network.  The CD2H also creates a social coding environment for translational science 
institutions, leveraging the community-driven DREAM challenges as a mechanism to stimulate 
innovation. To learn more, click here. 
 
 
RECRUITMENT AND RETENTION TOOLKIT: The Trial Innovation Network accepts toolkit submissions 
from CTSAs and reputable community health partners and provides them as a free resource to the 
research community.  The materials on this site are designed primarily for CTSA program staffs. These 
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resources are intended to provide a variety of information that includes best practices and evidence-
based recruitment and retention strategies. Full information can be found at 
https://trialinnovationnetwork.org/recruitment-retention-toolkit/?key-element=1681 
 
 
UMCCTS INTAKE PORTAL: The UMass Center for Clinical and Translational Science has implemented an 
intake/service request portal. Currently the portal is being utilized by the Office of Clinical Research for 
intake of all agreements and amendments. OnCore updates/corrections and Certificates of 
Confidentiality. The portal can be accessed on their newly updated website at 
https://www.umassmed.edu/ocr/ 
 
 
 
 
 
 
 
 
Have you had your research published that cites the UMass Center for Clinical and Translational Science?  
Has your patent been filed on technology developed using Center funding or resources? Did your pilot 
project receive external grant funding? Share it with us at ccts@umassmed.edu. Sharing your success 
demonstrates the importance and effect of the Center for Clinical and Translational Science at UMass!! 
 
 
 
 
Newsletter Submissions: To be included in the CCTS Monthly Newsletter, please send announcements, 
including a link, to ccts@umassmed.edu.  The newsletter is published the first business day of each month. 
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